HydraStat is our patented delivery system that shrinks nutrient particles small enough to absorb through the soft tissue in your mouthbypassing the gut entirely
extra strength and ultra strength
Overweight and obesity increase the risk of type 2 diabetes, heart disease, hypertension, and dyslipidemia, and are significant drivers of both morbidity and mortality
The FDA initially approved subcutaneous (SC) use Exenatide in 2005 and an oral version of semaglutide in 2019.2,3 Initially, GLP-1s were used exclusively for individuals with type 2 diabetes (T2DM) as a means to better control their blood sugar when paired with diet and exercise.2 Now their use is growing exponentially due to their success in helping patients achieve significant weight loss
Mounjaro vs Rybelsus: Switching Between Them At a glance Drug class / Mounjaro is a dual GIP/GLP-1 receptor agonist
Berberine: A Natural Ally for Type 2 Diabetes Type 2 diabetes is a condition characterized by insulin resistance and impaired blood sugar control